Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults.
about
Imiquimod for anogenital warts in non-immunocompromised adultsEffect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesionsAgents and strategies in development for improved management of herpes simplex virus infection and disease.Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.Resiquimod and other immune response modifiers as vaccine adjuvants.A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer.Microbial nucleic acids pay a Toll in kidney disease.Toll-like receptor modulation in cardiovascular disease: a target for intervention?Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignanciesImmunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.TLR7 and TLR8 as targets in cancer therapy.Resiquimod, a topical drug for viral skin lesions and skin cancer.Cancer vaccine adjuvants--recent clinical progress and future perspectives.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Biological Response Modifier in Cancer Immunotherapy.TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells.Rational design of small molecules as vaccine adjuvants.Innovative therapies in the treatment of keloids and hypertrophic scars.Topical resiquimod: a promising adjuvant for vaccine development?
P2860
Q24188125-2375047E-D46E-4EDC-A3CE-2929AF75D8ECQ24656625-A52FDB73-1536-4EDB-B4F0-31C2B55AA16BQ30350341-1CFF8289-C36B-4ADA-A4D6-D0BCE1FEE749Q33760871-08B02152-318F-4781-863A-61D41D4B9745Q33997622-9F48E784-E6FA-405B-9F68-EF66168C534BQ34260736-DAB2DD14-8E90-4085-A01D-6B6F71E27D88Q34700325-3D0A2A26-0355-4E10-B6DB-5CE6F6B2D922Q34778360-FFACAED0-D96E-4D26-88F5-A5929BB018AFQ35018021-89AABB24-5E2B-4C5D-8B33-13E1C92935E1Q35412152-0A2D1592-356D-4612-AC1D-1924CCDFDE6BQ35939623-2F1EBF1F-D3C8-4D68-8381-C878BA78199AQ36441718-218BD4D9-5E51-4AED-A89D-79D5F2F8C9D6Q36543054-949B93E5-5D94-43AD-BFD3-D84EC4BD43DBQ36802795-12F90D3A-97EF-40E2-8851-4825FCC5E5D2Q36973053-AC573B55-28A2-450A-B2D4-776D8D039AC1Q37051014-AC97531D-E5B9-4428-9993-3774D52D0A68Q38064483-11668E54-CFD6-4ECE-82D2-D85246A6F3EAQ38260496-C5F189D9-F9AD-4BB6-A041-123601F4E9E1Q38649653-46B31BA5-DF0A-49A6-A387-5AA5DAC481FAQ38848213-4EB2D4AD-84B5-4FEE-9996-0040D1F0365CQ39150078-76BEC283-AF9A-4C2B-A96B-6955D47E2C13Q41655108-F49BCBC1-BD0D-4B0C-8097-761164700E9AQ41813563-25F5716A-F554-4265-9A5C-8F67425F18C8Q43215434-96FB43FD-7CD2-4579-8D4C-80D849FE29EE
P2860
Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@ast
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@en
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@nl
type
label
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@ast
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@en
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@nl
prefLabel
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@ast
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@en
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@nl
P2093
P2860
P1476
Randomized, single-blind, plac ...... resiquimod in healthy adults.
@en
P2093
Daniel N Sauder
Inmaculada Soria
Michael H Smith
Therese Senta-McMillian
Tze-Chiang Meng
P2860
P304
P356
10.1128/AAC.47.12.3846-3852.2003
P407
P577
2003-12-01T00:00:00Z